PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SMMT vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between SMMT and SPY is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

SMMT vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Summit Therapeutics Inc. (SMMT) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%150.00%200.00%250.00%JulyAugustSeptemberOctoberNovemberDecember
79.88%
231.67%
SMMT
SPY

Key characteristics

Sharpe Ratio

SMMT:

2.20

SPY:

2.17

Sortino Ratio

SMMT:

5.48

SPY:

2.88

Omega Ratio

SMMT:

1.72

SPY:

1.41

Calmar Ratio

SMMT:

7.70

SPY:

3.19

Martin Ratio

SMMT:

26.18

SPY:

14.10

Ulcer Index

SMMT:

25.06%

SPY:

1.90%

Daily Std Dev

SMMT:

298.16%

SPY:

12.39%

Max Drawdown

SMMT:

-95.75%

SPY:

-55.19%

Current Drawdown

SMMT:

-42.59%

SPY:

-3.19%

Returns By Period

In the year-to-date period, SMMT achieves a 602.30% return, which is significantly higher than SPY's 24.97% return.


SMMT

YTD

602.30%

1M

-8.35%

6M

135.00%

1Y

655.88%

5Y*

66.12%

10Y*

N/A

SPY

YTD

24.97%

1M

-0.32%

6M

8.25%

1Y

26.85%

5Y*

14.57%

10Y*

12.92%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SMMT vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SMMT, currently valued at 2.20, compared to the broader market-4.00-2.000.002.002.202.17
The chart of Sortino ratio for SMMT, currently valued at 5.48, compared to the broader market-4.00-2.000.002.004.005.482.88
The chart of Omega ratio for SMMT, currently valued at 1.72, compared to the broader market0.501.001.502.001.721.41
The chart of Calmar ratio for SMMT, currently valued at 7.70, compared to the broader market0.002.004.006.007.703.19
The chart of Martin ratio for SMMT, currently valued at 26.18, compared to the broader market0.0010.0020.0026.1814.10
SMMT
SPY

The current SMMT Sharpe Ratio is 2.20, which is comparable to the SPY Sharpe Ratio of 2.17. The chart below compares the historical Sharpe Ratios of SMMT and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.002.003.004.005.00JulyAugustSeptemberOctoberNovemberDecember
2.20
2.17
SMMT
SPY

Dividends

SMMT vs. SPY - Dividend Comparison

SMMT has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 0.87%.


TTM20232022202120202019201820172016201520142013
SMMT
Summit Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
0.87%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%1.81%

Drawdowns

SMMT vs. SPY - Drawdown Comparison

The maximum SMMT drawdown since its inception was -95.75%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for SMMT and SPY. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-42.59%
-3.19%
SMMT
SPY

Volatility

SMMT vs. SPY - Volatility Comparison

Summit Therapeutics Inc. (SMMT) has a higher volatility of 17.56% compared to SPDR S&P 500 ETF (SPY) at 3.64%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%50.00%100.00%150.00%JulyAugustSeptemberOctoberNovemberDecember
17.56%
3.64%
SMMT
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab